Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics

0:00 The microbiome:  how much do we know today?

3:50 Glucose control leads product line

10:20 What about diagnostics in this space?

18:25 Upstream of GLP-1, which is made by the microbiome

23:25 Company goals, challenges

Fun fact:  we are composed of 90% bacterial cells and 10% human cells.  Surely, the company that begins to turn that knowledg…